Comparison between low-dose chemotherapy and surgery for the treatment of extremity-associated solitary bone lesions in children with Langerhans cell histiocytosis in South China: A case-control study
Conclusions Compared with surgery, LDC promotes more rapid recovery, is less invasive, is characterized by increased safety and a superior HRQOL, and is a more cost-effective treatment strategy for pediatric patients with SBL-LCH in the extremities.
Source: Journal of Bone Oncology - Category: Cancer & Oncology Source Type: research
More News: Alopecia | Cancer | Cancer & Oncology | Chemotherapy | Children | China Health | Histiocytosis | Langerhans Cell Histiocytosis (LCH) | Orthopaedics | Pediatrics | Study